Long-term persistence of hormonal adaptations to weight loss
- PMID: 22029981
- DOI: 10.1056/NEJMoa1105816
Long-term persistence of hormonal adaptations to weight loss
Abstract
Background: After weight loss, changes in the circulating levels of several peripheral hormones involved in the homeostatic regulation of body weight occur. Whether these changes are transient or persist over time may be important for an understanding of the reasons behind the high rate of weight regain after diet-induced weight loss.
Methods: We enrolled 50 overweight or obese patients without diabetes in a 10-week weight-loss program for which a very-low-energy diet was prescribed. At baseline (before weight loss), at 10 weeks (after program completion), and at 62 weeks, we examined circulating levels of leptin, ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide 1, amylin, pancreatic polypeptide, cholecystokinin, and insulin and subjective ratings of appetite.
Results: Weight loss (mean [±SE], 13.5±0.5 kg) led to significant reductions in levels of leptin, peptide YY, cholecystokinin, insulin (P<0.001 for all comparisons), and amylin (P=0.002) and to increases in levels of ghrelin (P<0.001), gastric inhibitory polypeptide (P=0.004), and pancreatic polypeptide (P=0.008). There was also a significant increase in subjective appetite (P<0.001). One year after the initial weight loss, there were still significant differences from baseline in the mean levels of leptin (P<0.001), peptide YY (P<0.001), cholecystokinin (P=0.04), insulin (P=0.01), ghrelin (P<0.001), gastric inhibitory polypeptide (P<0.001), and pancreatic polypeptide (P=0.002), as well as hunger (P<0.001).
Conclusions: One year after initial weight reduction, levels of the circulating mediators of appetite that encourage weight regain after diet-induced weight loss do not revert to the levels recorded before weight loss. Long-term strategies to counteract this change may be needed to prevent obesity relapse. (Funded by the National Health and Medical Research Council and others; ClinicalTrials.gov number, NCT00870259.).
Comment in
-
Long-term hormonal adaptations to weight loss.N Engl J Med. 2012 Jan 26;366(4):380-1; author reply 382. doi: 10.1056/NEJMc1113675. N Engl J Med. 2012. PMID: 22276835 No abstract available.
-
Long-term hormonal adaptations to weight loss.N Engl J Med. 2012 Jan 26;366(4):381; author reply 382. doi: 10.1056/NEJMc1113675. N Engl J Med. 2012. PMID: 22276836 No abstract available.
-
Long-term hormonal adaptations to weight loss.N Engl J Med. 2012 Jan 26;366(4):381-2; author reply 382. doi: 10.1056/NEJMc1113675. N Engl J Med. 2012. PMID: 22276837 No abstract available.
Similar articles
-
Ketosis and appetite-mediating nutrients and hormones after weight loss.Eur J Clin Nutr. 2013 Jul;67(7):759-64. doi: 10.1038/ejcn.2013.90. Epub 2013 May 1. Eur J Clin Nutr. 2013. PMID: 23632752
-
Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.N Engl J Med. 2002 May 23;346(21):1623-30. doi: 10.1056/NEJMoa012908. N Engl J Med. 2002. PMID: 12023994
-
Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people.Gastroenterology. 2006 Dec;131(6):1717-24. doi: 10.1053/j.gastro.2006.10.025. Epub 2006 Oct 15. Gastroenterology. 2006. PMID: 17087952
-
Gut-brain communication: how does it stand after bariatric surgery?Curr Opin Clin Nutr Metab Care. 2006 Sep;9(5):629-36. doi: 10.1097/01.mco.0000241676.63041.11. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16912562 Review.
-
Gut peptides and the regulation of appetite.Obes Rev. 2006 May;7(2):163-82. doi: 10.1111/j.1467-789X.2006.00245.x. Obes Rev. 2006. PMID: 16629873 Review.
Cited by
-
Surgical or medical treatment of obesity-associated type 2 diabetes-an increasing clinical conundrum.World J Diabetes. 2024 Oct 15;15(10):2036-2040. doi: 10.4239/wjd.v15.i10.2036. World J Diabetes. 2024. PMID: 39493561 Free PMC article.
-
Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product.Obes Pillars. 2024 Sep 30;12:100138. doi: 10.1016/j.obpill.2024.100138. eCollection 2024 Dec. Obes Pillars. 2024. PMID: 39416284 Free PMC article.
-
New Application of an Old Drug: Anti-Diabetic Properties of Phloroglucinol.Int J Mol Sci. 2024 Sep 24;25(19):10291. doi: 10.3390/ijms251910291. Int J Mol Sci. 2024. PMID: 39408621 Free PMC article. Review.
-
Psychometric Properties of the Preference for Intuition and Deliberation in Eating Decision-Making Scale among Brazilian Adult Women.Nutrients. 2024 Sep 26;16(19):3252. doi: 10.3390/nu16193252. Nutrients. 2024. PMID: 39408219 Free PMC article.
-
Overview of the therapeutic efficacy of marine fish oil in managing obesity and associated metabolic disorders.Physiol Rep. 2024 Oct;12(19):e70019. doi: 10.14814/phy2.70019. Physiol Rep. 2024. PMID: 39358834 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical